Literature DB >> 8642654

Protease-induced infectivity of hepatitis B virus for a human hepatoblastoma cell line.

X Lu1, T M Block, W H Gerlich.   

Abstract

The human hepatoblastoma cell line HepG2 produces and secretes hepatitis B virus (HBV) after transfection of cloned HBV DNA. Intact virions do not infect these cells, although they attach to the surface of the HepG2 cell through binding sites in the pre-S1 domain. Entry of enveloped virions into the cell often requires proteolytic cleavage of a viral surface protein that is involved in fusion between the cell membrane and the viral envelope. Recently, we observed pre-S-independent, nonspecific binding between hepatitis B surface (HBs) particles and HepG2 cells after treatment of HBs antigen particles with V8 protease, which cleaves next to a putative fusion sequence. Chymotrypsin removed this fusion sequence and did not induce binding. In this study, we postulate that lack of a suitable fusion-activating protease was the reason why the HepG2 cells were not susceptible to HBV. To test this hypothesis, virions were partially purified from the plasma of HBV carriers and treated with either staphylococcal V8 or porcine chymotrypsin protease. Protease-digested virus lost reactivity with pre-S2-specific antibody but remained morphologically intact as determined by electron microscopy. After separation from the proteases, virions were incubated with HepG2 cells at pH 5.5. Cultures inoculated with either intact or chymotrypsin-digested virus did not contain detectable levels of intracellular HBV DNA at any time following infection. However, in cultures inoculated with V8-digested virions, HBV-specific products, including covalently closed circular DNA, viral RNA, and viral pre-S2 antigen, could be detected in a time-dependent manner following infection. Immunofluorescence analysis revealed that 10 to 30% of the infected HepG2 cells produced HBV antigen. Persistent secretion of virus by the infected HepG2 cells lasted at least 14 days and was maintained during several reseeding steps. The results show that V8-digested HBV can productively infect tissue cultures of HepG2 cells. It is suggested that proteolysis-dependent exposure of a fusion domain within the envelope protein of HBV is necessary during natural infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642654      PMCID: PMC190069     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Mung bean nuclease I. Physical, chemical, and catalytic properties.

Authors:  D Kowalski; W D Kroeker; M Laskowski
Journal:  Biochemistry       Date:  1976-10-05       Impact factor: 3.162

2.  Large surface proteins of hepatitis B virus containing the pre-s sequence.

Authors:  K H Heermann; U Goldmann; W Schwartz; T Seyffarth; H Baumgarten; W H Gerlich
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

3.  Structural relationships between minor and major proteins of hepatitis B surface antigen.

Authors:  W Stibbe; W H Gerlich
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

4.  Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

Authors:  M A Sells; M L Chen; G Acs
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

5.  Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus.

Authors:  A R Neurath; S B Kent; N Strick; K Parker
Journal:  Cell       Date:  1986-08-01       Impact factor: 41.582

6.  Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells.

Authors:  J S Tuttleman; C Pourcel; J Summers
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

7.  Adsorption and penetration of hepatitis B virus in a nonpermissive cell line.

Authors:  M Qiao; T B Macnaughton; E J Gowans
Journal:  Virology       Date:  1994-06       Impact factor: 3.616

8.  In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus.

Authors:  J S Tuttleman; J C Pugh; J W Summers
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

9.  Phospholipid interactions of the putative fusion peptide of hepatitis B virus surface antigen S protein.

Authors:  I Rodríguez-Crespo; E Núñez; J Gómez-Gutiérrez; B Yélamos; J P Albar; D L Peterson; F Gavilanes
Journal:  J Gen Virol       Date:  1995-02       Impact factor: 3.891

10.  Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion.

Authors:  X Lu; A Mehta; R Dwek; T Butters; T Block
Journal:  Virology       Date:  1995-11-10       Impact factor: 3.616

View more
  25 in total

1.  Identification of a structural motif crucial for infectivity of hepatitis B viruses.

Authors:  Lars Stoeckl; Anneke Funk; Ariane Kopitzki; Boerries Brandenburg; Stefanie Oess; Hans Will; Hüseyin Sirma; Eberhard Hildt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-17       Impact factor: 11.205

2.  Prevention of de novo HBV infection by the presence of anti-HBs in transplanted patients receiving core antibody-positive livers.

Authors:  Rafael Barcena; Gloria Moraleda; Javier Moreno; M Dolores Martín; Emilio de Vicente; Jesús Nuño; M Luisa Mateos; Santos del Campo
Journal:  World J Gastroenterol       Date:  2006-04-07       Impact factor: 5.742

Review 3.  Viral and cellular determinants involved in hepadnaviral entry.

Authors:  Dieter Glebe; Stephan Urban
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 4.  Molecular virology of hepatitis B virus for clinicians.

Authors:  Timothy M Block; Haitao Guo; Ju-Tao Guo
Journal:  Clin Liver Dis       Date:  2007-11       Impact factor: 6.126

5.  Entry of duck hepatitis B virus into primary duck liver and kidney cells after discovery of a fusogenic region within the large surface protein.

Authors:  Claudia Maenz; Shau-Feng Chang; Alicja Iwanski; Michael Bruns
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

6.  Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients.

Authors:  S Stoll-Becker; R Repp; D Glebe; S Schaefer; J Kreuder; M Kann; F Lampert; W H Gerlich
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

7.  Hepatitis B virus infection and replication in primarily cultured human fetal hepatocytes.

Authors:  Min Lin; Qun Chen; Li-Ye Yang; Wen-Yu Li; Xi-Biao Cao; Jiao-Ren Wu; You-Peng Peng; Mo-Rui Chen
Journal:  World J Gastroenterol       Date:  2007-02-21       Impact factor: 5.742

8.  Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues.

Authors:  Matthieu Blanchet; Camille Sureau
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

9.  A hydrophobic domain in the large envelope protein is essential for fusion of duck hepatitis B virus at the late endosome.

Authors:  J Chojnacki; D A Anderson; E V L Grgacic
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

10.  Screening and identification of compounds with antiviral activity against hepatitis B virus using a safe compound library and novel real-time immune-absorbance PCR-based high throughput system.

Authors:  Jason Lamontagne; Courtney Mills; Richeng Mao; Cally Goddard; Dawei Cai; Haitao Guo; Andy Cuconati; Timothy Block; Xuanyong Lu
Journal:  Antiviral Res       Date:  2013-02-13       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.